![]() ![]() In addition to the University of Helsinki, it includes IBM Research, the European Molecular Biology Laboratory, the University of Siena and the University of Turin in Italy, the University of Tartu in Estonia, the Biobanks and Biomolecular Resources Research Infrastructure Consortium (BBMRI) in Austria, Technical University of Munich in Germany the European Cancer Patient Coalition in Brussels, the University of Cambridge and Queen Mary University of London in the UK, the Norwegian University of Science and Technology, Massachusetts General Hospital in the US, and other partners. ![]() The official name of Intervene is the International Consortium for Integrative Genomics Prediction. "If we can show how that is done, and how it works as a model, that will have a huge impact downstream," he said. "I think the downstream effects will be that we will show how to link genetic risk data to the clinics," said Samuli Ripatti, a professor of biometry at the University of Helsinki and the principal investigator on the project. According to the organizers, the project could catapult Europe to a leading position for translating genetic findings into the clinic. It involves 18 partners, including one in the US, and will oversee multiple pilot studies, as well as the development of an AI-enabled federated data analysis platform. The effort is backed by EU Horizon 2020 funding and is set to end in December 2025. Called Intervene, the €10.4 million ($12.6 million) project will use genomic and health data from biorepositories along with machine learning methods to develop new clinical predictive tools. NEW YORK – A new European consortium has placed some of the region's largest biobanks and most innovative informaticians and clinicians under a single banner. Advances in Clinical Genomics Profiling.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |